LIPJ activators comprise a chemical class that targets the biochemical pathway involving the LIPJ protein, which takes part in a specific cellular process. The exact nature of this protein within the cellular milieu is complex, as it interacts with various substrates and other proteins, thereby influencing numerous biochemical cascades. LIPJ activators work by modulating the activity of the LIPJ protein, which can lead to alterations in the protein's natural behavior and function within the cell. The activation of the LIPJ protein through these chemical agents can affect the protein's conformation, stability, or its interaction with other cellular components. These activators are designed based on the structural understanding of the LIPJ protein, often requiring detailed knowledge of its active site or other key regions that are critical for its function. By binding to these sites, LIPJ activators can enhance the protein's intrinsic activity, often by promoting a more active conformation or by stabilizing the protein in a state that is more conducive to its role within the cell.
The development of LIPJ activators involves extensive research into the protein's structure-function relationships, the dynamics of its interactions within the cell, and the pathways that are affected by its activity. By focusing on the LIPJ protein, scientists aim to create molecules that are highly specific in their action, thereby minimizing off-target effects that can arise from interactions with other proteins that might have similar structural features. The specificity and efficacy of LIPJ activators are critical, as the precise modulation of the LIPJ protein's activity is essential for the intended biochemical outcomes. In addition to specificity, factors such as stability, solubility, and the ability to reach the target site within a cell are also important considerations in the development of these activators. As a result, the field of LIPJ activator development encompasses a wide range of disciplines, including biochemistry, molecular biology, pharmacology, and organic chemistry, each contributing to the intricate process of creating and refining these complex chemical entities.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate LIPJ, enhancing its enzymatic activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, preventing the breakdown of cAMP. By maintaining high cAMP levels, IBMX indirectly promotes PKA activity, which can lead to the phosphorylation and activation of LIPJ. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can lead to the phosphorylation of downstream proteins that interact with LIPJ, indirectly enhancing its function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, activating calcium-dependent protein kinases. These kinases can phosphorylate and activate LIPJ. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore similar to Ionomycin, increasing intracellular calcium levels and potentially activating calcium-dependent protein kinases that enhance LIPJ activity. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $83.00 | 1 | |
FPL 64176 is a calcium channel agonist that increases intracellular calcium levels, promoting the activation of calcium-dependent signaling pathways that can phosphorylate and activate LIPJ. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels by activating adenylyl cyclase, leading to the activation of PKA, which can then enhance LIPJ activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, through its action on beta-adrenergic receptors, increases cAMP production and activates PKA, which can phosphorylate LIPJ, thereby enhancing its activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins. This can indirectly result in the enhanced activity of LIPJ through prolonged phosphorylation. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is a selective inhibitor of phosphodiesterase type 5 (PDE5), which prevents the breakdown of cAMP. By increasing cAMP levels, Zaprinast may indirectly facilitate LIPJ activation through PKA signaling. | ||||||